Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COOLXENON3: Xenon gas plus therapeutic hypothermia in neonates after hypoxic-ischaemic insult
2013-004478-80Phase 2Unknown
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Apr 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of xenon in Neonatal hypoxic-ischemic encephalopathy (HIE) and asphyxia neonatorum (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Bayley neurodevelopmental outcome scores. Status: unknown.
02
Drugs
xenon
03
Conditions
Neonatal hypoxic-ischemic encephalopathy (HIE)asphyxia neonatorum
Beyond the preview
Go deeper on 2013-004478-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004478-80.